Liver metabolic and synthetic pathways

Liver metabolic and synthetic pathways represent the collective biochemical processes occurring within hepatocytes that maintain systemic homeostasis (StatPearls, 2023). These pathways are responsible for the synthesis of essential plasma proteins, such as albumin and clotting factors, as well as the regulation of carbohydrate, lipid, and amino acid metabolism (NIH, 2023). The liver also plays a critical role in the detoxification of endogenous metabolites like ammonia and the biotransformation of exogenous substances through Phase I and Phase II metabolic reactions (Wikipedia, 2024). Impairment of these pathways leads to significant clinical manifestations, including jaundice, coagulopathy, and hepatic encephalopathy, often seen in chronic liver diseases or acute failure (PubMed, 2022). While not a single molecular target, these pathways contain numerous specific enzymes and receptors, such as HMG-CoA reductase or PPAR-gamma, which are targeted by various pharmacological agents to treat metabolic and cardiovascular conditions (DrugBank, 2024). Monitoring these pathways is essential in clinical practice using biomarkers like transaminases and bilirubin to assess liver health and drug safety (StatPearls, 2023).

Other names

Hepatic metabolismLiver functionHepatic biosynthetic pathwaysHepatic metabolic processes

Drugs interact with specific enzymes, transporters, or nuclear receptors within these pathways to modulate glucose production, lipid synthesis, protein translation, or detoxification rates (DrugBank, 2024).